Literature DB >> 21495217

Systemic leukocyte alterations are associated with invasive uterine cervical cancer.

Beatriz M Tavares-Murta1, Maria A O Mendonça, Natália L Duarte, Juliana A da Silva, Taciana S Mutão, Cristiana B Garcia, Eddie F C Murta.   

Abstract

OBJECTIVE: The aim of the study was to evaluate blood leukocyte counts in patients with uterine cervical neoplasia.
METHODS: Patients treated at a university hospital were reviewed retrospectively. Disease progression was monitored, beginning in 1990 to 2002, for at least 5 years. Blood count parameters included absolute leukocyte, neutrophil and lymphocyte counts, leukocytosis (white blood cells > 10³/μL), neutrophilia (neutrophils ≥ 70% of leukocytes), lymphopenia (lymphocytes ≤ 15% of leukocytes), and the neutrophil-lymphocyte ratio (NLR), categorized as less than 5 or 5 or greater.
RESULTS: A total of 315 patients were enrolled: 182 (57.8%) with preinvasive neoplasia (cervical intraepithelial neoplasia [CIN] group), 95 (30.1%) with stages I to II (early group), and 38 patients (12.1%) with stages III to IV neoplasia (advanced group). Neutrophil and lymphocyte counts were elevated and reduced, respectively, at advanced stages compared with the CIN group (P < 0.05). Leukocytosis, neutrophilia, lymphopenia, and an NLR of 5 or greater were more frequent at advanced stages compared with the CIN and early-stage groups (P < 0.05). Moreover, neutrophilia was also significantly more frequent at early stage compared with the CIN group. The advanced group with neutrophilia had increased frequency of recidivism and metastasis than patients in the CIN group with neutrophilia (P < 0.05).
CONCLUSIONS: Patients with advanced cervical cancer had significantly higher frequency of leukocyte alterations, although they may occur apart from the preinvasive stages. Overall, neutrophilia was the best indicator of cancer invasiveness.

Entities:  

Mesh:

Year:  2010        PMID: 21495217     DOI: 10.1111/igc.0b013e3181ef8deb

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  20 in total

Review 1.  DNA methylation in white blood cells: association with risk factors in epidemiologic studies.

Authors:  Mary Beth Terry; Lissette Delgado-Cruzata; Neomi Vin-Raviv; Hui Chen Wu; Regina M Santella
Journal:  Epigenetics       Date:  2011-07-01       Impact factor: 4.528

2.  White blood cell global methylation and IL-6 promoter methylation in association with diet and lifestyle risk factors in a cancer-free population.

Authors:  Fang Fang Zhang; Regina M Santella; Mary Wolff; Maya A Kappil; Steven B Markowitz; Alfredo Morabia
Journal:  Epigenetics       Date:  2012-06-01       Impact factor: 4.528

Review 3.  Epigenetic Biomarkers of Breast Cancer Risk: Across the Breast Cancer Prevention Continuum.

Authors:  Mary Beth Terry; Jasmine A McDonald; Hui Chen Wu; Sybil Eng; Regina M Santella
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

4.  Neutrophil-lymphocyte ratio predicts overall and recurrence-free survival after liver transplantation for hepatocellular carcinoma.

Authors:  Alpna R Limaye; Virginia Clark; Consuelo Soldevila-Pico; Giuseppe Morelli; Amitabh Suman; Roberto Firpi; David R Nelson; Roniel Cabrera
Journal:  Hepatol Res       Date:  2012-11-30       Impact factor: 4.288

5.  Development and Validation of a Nomogram for Preoperative Prediction of Central Compartment Lymph Node Metastasis in Patients with Papillary Thyroid Carcinoma and Type 2 Diabetes Mellitus.

Authors:  Yiqiao Lu; Binqi Wang; Chao He; Jie He; Haiguang Liu; Xiaohua Zhang
Journal:  Cancer Manag Res       Date:  2021-03-17       Impact factor: 3.989

6.  Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study.

Authors:  Kemal Gungorduk; Ibrahim E Ertas; Aykut Ozdemir; Emrah Akkaya; Elcin Telli; Salih Taskin; Mehmet Gokcu; Ahmet Baris Guzel; Tufan Oge; Levent Akman; Tayfun Toptas; Ulas Solmaz; Askın Dogan; Mustafa Cosan Terek; Muzaffer Sanci; Aydin Ozsaran; Tayyup Simsek; Mehmet Ali Vardar; Omer Tarik Yalcin; Sinan Ozalp; Yusuf Yildirim; Firat Ortac
Journal:  Cancer Res Treat       Date:  2014-11-17       Impact factor: 4.679

7.  Diabetes mellitus and the neutrophil to lymphocyte ratio predict overall survival in non-viral hepatocellular carcinoma treated with transarterial chemoembolization.

Authors:  Jiangguo Zhang; Fengyun Gong; Ling Li; Manzhi Zhao; Jianxin Song
Journal:  Oncol Lett       Date:  2014-02-20       Impact factor: 2.967

8.  Preoperative neutrophil-lymphocyte and platelet-lymphocyte ratios as independent predictors of cervical stromal involvement in surgically treated endometrioid adenocarcinoma.

Authors:  Dan Wang; Jia-Xin Yang; Dong-Yan Cao; Xi-Run Wan; Feng-Zhi Feng; Hui-Fang Huang; Keng Shen; Yang Xiang
Journal:  Onco Targets Ther       Date:  2013-03-16       Impact factor: 4.147

9.  Parameters of blood count and tumor markers in patients with borderline ovarian tumors: a retrospective analysis and relation to staging.

Authors:  Rosekeila Simões Nomelini; Taísa Morete da Silva; Beatriz Martins Tavares Murta; Eddie Fernando Candido Murta
Journal:  ISRN Oncol       Date:  2012-04-17

10.  Peripheral blood cells inform on the presence of breast cancer: a population-based case-control study.

Authors:  Vanessa Dumeaux; Josie Ursini-Siegel; Arnar Flatberg; Hans E Fjosne; Jan-Ole Frantzen; Marit Muri Holmen; Enno Rodegerdts; Ellen Schlichting; Eiliv Lund
Journal:  Int J Cancer       Date:  2014-06-25       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.